Published in Cancer Weekly, December 12th, 2006
The meeting also featured presentations on Adherex's Phase I single-agent trials of ADH-1 as well as the preclinical studies of ADH-1 in combination with chemotherapy.
Dr. Robert B. Diasio, professor, Department of Molecular Pharmacology and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.